BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28129947)

  • 21. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
    Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
    Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular chaperone mediated late-stage neuroprotection in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Novoselov SS; Mustill WJ; Gray AL; Dick JR; Kanuga N; Kalmar B; Greensmith L; Cheetham ME
    PLoS One; 2013; 8(8):e73944. PubMed ID: 24023695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis.
    Yip PK; Pizzasegola C; Gladman S; Biggio ML; Marino M; Jayasinghe M; Ullah F; Dyall SC; Malaspina A; Bendotti C; Michael-Titus A
    PLoS One; 2013; 8(4):e61626. PubMed ID: 23620776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.
    Noor Eddin A; Alfuwais M; Noor Eddin R; Alkattan K; Yaqinuddin A
    Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel insights into RAGE signaling pathways during the progression of amyotrophic lateral sclerosis in RAGE-deficient SOD1 G93A mice.
    Nowicka N; Zglejc-Waszak K; Juranek J; Korytko A; Wąsowicz K; Chmielewska-Krzesińska M; Wojtkiewicz J
    PLoS One; 2024; 19(3):e0299567. PubMed ID: 38457412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
    Stoica L; Todeasa SH; Cabrera GT; Salameh JS; ElMallah MK; Mueller C; Brown RH; Sena-Esteves M
    Ann Neurol; 2016 Apr; 79(4):687-700. PubMed ID: 26891182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic modulation of motor neurons through the C-boutons are necessary for the locomotor compensation for severe motor neuron loss during amyotrophic lateral sclerosis disease progression.
    Landoni LM; Myles JR; Wells TL; Mayer WP; Akay T
    Behav Brain Res; 2019 Sep; 369():111914. PubMed ID: 31022419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Gento-Caro Á; Vilches-Herrando E; Portillo F; González-Forero D; Moreno-López B
    Brain Pathol; 2022 May; 32(3):e13022. PubMed ID: 34585475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative analysis of metabolomics and proteomics unravels purine metabolism dysregulation in the SOD1
    Xu X; Yang Q; Liu Z; Zhang R; Yu H; Wang M; Chen S; Xu G; Shao Y; Le W
    Neurobiol Dis; 2023 Jun; 181():106110. PubMed ID: 37001614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis.
    Cox LM; Calcagno N; Gauthier C; Madore C; Butovsky O; Weiner HL
    Microbiome; 2022 Mar; 10(1):47. PubMed ID: 35272713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis.
    Nandar W; Neely EB; Simmons Z; Connor JR
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2413-26. PubMed ID: 25283820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model.
    Post J; Kogel V; Schaffrath A; Lohmann P; Shah NJ; Langen KJ; Willbold D; Willuweit A; Kutzsche J
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33805709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
    Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
    Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.